Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
World Journal of Surgery
Published in: World Journal of Surgery 8/2006

01-08-2006

Biomedical Industrial Sponsorship and Its Impact on the Medical Literature

Author: Peter J. Morris, AC, FRS, FRCS

Published in: World Journal of Surgery | Issue 8/2006

Login to get access

Excerpt

The pharmaceutical industry plays a vital role in the development of new drugs. The industry is involved at two levels. The first is in the design and discovery of new drugs, which may occur in their own laboratories or in the university environment. The second is the research and development that brings a drug onto the market as a result of clinical trials; the latter take place in the clinic in both university and nonuniversity institutions and, for the most part, are sponsored by industry. …
Literature
1.
2.
Montaner JSG, O’Shaughnessy MV, Schechter T. Industry-sponsored clinical research: a double edged sword. Lancet 2001;358:1893PubMedCrossRef
3.
4.
5.
6.
Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167PubMedCrossRef
7.
Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Can Med Assoc J 2004;170:477
8.
Melander H, Ahlqvist-Rastad J, Meijer B, et al. Evidence b(i)ased medicine: selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003;326:xCrossRef
9.
Als-Nielsen B, Chen W, Gluud C, et al. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events. JAMA 2003;290:921PubMedCrossRef
10.
Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med 1996;124:485PubMed
11.
Bekelman JE, Li Y, Gross GP. Scope and impact of financial conflicts of interest in biomedical research. JAMA 2003;289:454PubMedCrossRef
12.
Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002;287:612PubMedCrossRef
13.
Stelfox HT, Chua G, O’Rourke K, et al. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998;338:101PubMedCrossRef
Metadata
Title
Biomedical Industrial Sponsorship and Its Impact on the Medical Literature
Author
Peter J. Morris, AC, FRS, FRCS
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 8/2006
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-0710-9

Other articles of this Issue 8/2006

World Journal of Surgery 8/2006 Go to the issue

OriginalPaper

Specific Targeting of Pancreatic Islet Cells In Vivo by Insulin-Promoter-Driven Adenoviral Conjugated Reporter Genes

OriginalPaper

Phyllodes Tumor of the Breast: The Challenge Persists

OriginalPaper

Gastric Cancer Surgery in Elderly Patients

OriginalPaper

Postsurgical Infections are Reduced with Specialized Nutrition Support

OriginalPaper

Identification of Patients at Low Risk for Thyroidectomy-Related Hypocalcemia by Intraoperative Quick PTH

OriginalPaper

Improved Long-term Survival after Liver Resection for Hepatocellular Carcinoma in the Modern Era: Retrospective Study from HCV-endemic Areas